CAS Number 928822-98-4 ChemSpider 21106245 3D model (Jmol) Interactive image | PubChem CID 50878551 Formula C17H22N2O Molar mass 270.375 g/mol | |
![]() | ||
5 meo dalt experience report
5-MeO-DALT or N,N-di allyl-5-methoxy tryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.
Contents
- 5 meo dalt experience report
- Sasha shulgin 5 meo dalt 2c b fly 5 etos
- Chemistry
- Pharmacology
- History
- Dosage
- Side effects
- China
- Japan
- United Kingdom
- Singapore
- Sweden
- United States
- Florida
- Louisiana
- References
Sasha shulgin 5 meo dalt 2c b fly 5 etos
Chemistry
The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl] prop-2-en-1- amine. It is related to the compounds 5-MeO-DPT and DALT.
Pharmacology
5-MeO-DALT binds to 5-HT1A, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6, α2A, α2B, α2C, H1, κ-opioid, σ1 and σ2 receptors with Ki values lower than 10μM and also acts as a DAT and SERT monoamine reuptake inhibitor.
The metabolism and cytochrome P450 inhibition of 5-MeO-DALT has been described in scientific literature.
History
The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a research associate named Murple in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors after being synthesized by commercial laboratories in China. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid.
Dosage
Doses ranging from 12–20 mg were tested by Alexander Shulgin's research group.
Side effects
There is no published literature on the toxicity of 5-MeO-DALT.
China
As of October 2015 5-MeO-DALT is a controlled substance in China.
Japan
5-MeO-DALT became a controlled substance in Japan from April 2007, by amendment to the Pharmaceutical Affairs Law.
United Kingdom
5-MeO-DALT became a Class A drug in the UK on January 7th 2015 after an update to the tryptamine blanket ban.
Singapore
5-MeO-DALT is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.
Sweden
Sveriges riksdag added 5-MeO-DALT to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of May 1, 2012, published by Medical Products Agency in their regulation LVFS 2012:6 listed as 5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin.
United States
5-MeO-DALT is not scheduled at the federal level in the United States, but it is likely that it could be considered an analog of 5-Meo-DiPT or another tryptamine, in which case purchase, sale, or possession could be prosecuted under the Federal Analog Act.
Florida
5-MeO-DALT is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.
Louisiana
5-MeO-DALT is a Schedule I controlled substance in the state of Louisiana making it illegal to buy, sell, or possess in Louisiana.